Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NPD-1911
- Development stage
- Unknown
- Lead developer
- Nogra Pharma Ltd.
- Modality
- Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
01
Overview
NPD-1911 is an investigational oligonucleotide therapeutic being developed by Nogra Pharma for the treatment of immune-inflammatory-mediated diseases, including Crohn's disease. It is part of Nogra Pharma's proprietary oligonucleotide platform, which focuses on designing synthetic oligonucleotides capable of down-regulating the expression of specific target proteins involved in inflammatory pathways. While the exact molecular target and mechanism of action have not been publicly disclosed, the drug is currently in Phase I clinical development, following the company's strategy of targeting immune-mediated conditions with RNA-based therapies.
Beyond the preview
Go deeper on NPD-1911.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NPD-1911.